Takeda Ruling Could Limit FCA Enforcement, 1st Circ. Hears

Law360, Los Angeles (August 02, 2013, 8:26 PM ET) -- The federal government on Thursday asked the First Circuit to overturn a ruling that Takeda Pharmaceutical Co. Ltd. wasn't liable for failure to tell the U.S. Food and Drug Administration about health complications tied to its drugs, arguing the decision would limit the government's False Claims Act enforcement.

A former Takeda contractor claims in two qui tam suits that the company cost the government billions in overpayments by not reporting the alleged health risks. But a Massachusetts federal judge ruled last year that the potential of the...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required